Fonte: Frontiers in Pharmacology. Unidades: FM, FCF
Assuntos: METABÓLITOS, TABAGISMO
ABNT
TOMAZ, Paulo Roberto Xavier et al. Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion. Frontiers in Pharmacology, v. 13, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.900112. Acesso em: 16 nov. 2024.APA
Tomaz, P. R. X., Gonçalves, T. S., Santos, J. R., Scholz, J., Abe, T. O., Gaya, P. V., et al. (2022). Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion. Frontiers in Pharmacology, 13, 1-7. doi:10.3389/fphar.2022.900112NLM
Tomaz PRX, Gonçalves TS, Santos JR, Scholz J, Abe TO, Gaya PV, Figueiredo EC, Faria HD de, Martins I, Pego AMF, Paranhos BAPB, Yonamine M, Pereira AC, Santos PCJL. Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-7.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fphar.2022.900112Vancouver
Tomaz PRX, Gonçalves TS, Santos JR, Scholz J, Abe TO, Gaya PV, Figueiredo EC, Faria HD de, Martins I, Pego AMF, Paranhos BAPB, Yonamine M, Pereira AC, Santos PCJL. Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-7.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fphar.2022.900112